Drug Information Related to Paremyd
01. Akorn Acquires Paredrine - Specialty Ophthalmic Diagnostic Product Fro...
BUFFALO GROVE, IL--(BUSINESS WIRE)--March 24, 1999--Akorn, Inc. (NASDAQ: AKRN) today announced the acquisition of the specialty ophthalmic diagnostic product, Paredrine. The purchase includes the worldwide rights and title to the NDA to include the trademarks and tra...
02. Akorn, Inc. Reports Record Third Quarter and Nine Months Results ......
BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Oct. 20, 1998--Third Quarter Sales Increase 37 Percent and Net Income Increases 58Percent Before Charges for Purchased R&D and Withdrawal of
StockOfferingAkorn, Inc. (NASDAQ:AKRN) today announced record results for the
third...
03. Equip your examination room: a checklist of office essentials ...
...
04. Fighting infection the smart way | Optometric Management | Find ......
Recent research shows that levofloxacin is a worthy aid in comanaging cataract cases.
...